Table 3.
Changes in PSA levels in prostate cancer patients treated with troglitazone
Changes in PSA | Overall, n = 41 | Androgen-dependent, n = 12 | Androgen-independent, n = 29 |
---|---|---|---|
>50% Decrease | 1/41 | 1/12 | 0/29 |
<50% Decrease | 7/41 | 3/12 | 4/29 |
No decrease | 33/41 | 8/12 | 25/29 |
Median time on study | 18+ weeks | 20+ weeks | 18+ weeks |